User:Mr. Ibrahem/Fludarabine

Fludarabine, sold under the brand name Fludara among others, is a chemotherapy medication used in the treatment of leukemia and lymphoma. These include chronic lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia, and acute lymphocytic leukemia. It is given by injection into a vein or by mouth.

Common side effects include nausea, diarrhea, fever, rash, shortness of breath, numbness, vision changes, and feeling tired. Severe side effects include brain dysfunction, low blood cell counts, and lung inflammation. Use in pregnancy will likely result in harm to the baby. Fludarabine is in the purine analog family of medications and works by interfering with the duplication of DNA.

Fludarabine was approved for medical use in the United States in 1991. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is about US$54 per 50 mg vial. In the United Kingdom it costs about 155 pounds per 50 mg vial.